Related Experiment Videos
Sonodynamically-induced cell damage with fluorinated anthracycline derivative, FAD104
N Yumita1, S Umemura, M Kaneuchi
1School of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan.
Cancer Letters
|May 5, 1998
Summary
The fluorine-containing anthracycline derivative (FAD104) enhanced ultrasound-induced cell damage in vitro. This effect, potentially mediated by sonochemistry, was inhibited by histidine.
Area of Science:
- Biochemistry
- Cell Biology
- Medical Physics
Background:
- Ultrasound is used in various medical applications.
- Anthracycline derivatives are known for their biological activity.
- Investigating novel drug delivery and therapeutic enhancement methods is crucial.
Purpose of the Study:
- To investigate the in vitro cell damaging effects of a fluorine-containing anthracycline derivative (FAD104) when combined with ultrasound.
- To explore the potential sonochemical mechanisms involved in FAD104-mediated cell damage.
Main Methods:
- Sarcoma 180 cells were suspended in air-saturated phosphate-buffered saline (PBS).
- Cells were exposed to ultrasound for up to 60 seconds.
- The effects of FAD104 (80 microM) alone and in combination with ultrasound were assessed.
- The role of histidine in inhibiting the observed effects was examined.
Main Results:
- The combination of ultrasound and 80 microM FAD104 doubled the rate of induced cell damage compared to ultrasound alone.
- FAD104 alone did not cause significant cell damage.
- Histidine significantly inhibited the enhancement of cell damage, suggesting a sonochemical mechanism.
Conclusions:
- FAD104 acts as a sonosensitizer, enhancing ultrasound-induced cell damage in vitro.
- The mechanism likely involves sonochemical reactions, as indicated by histidine's inhibitory effect.
- This finding suggests potential applications for FAD104 in ultrasound-mediated therapies.